[EMAIL]: INFO@HELLENICDYNAMICS.COM
[TEL]: +44 (0)207 491 8484
[EMAIL]: INFO@HELLENICDYNAMICS.COM
[TEL]: +44 (0)207 491 8484
Founded in 2018, Hellenic Dynamics is a licensed cultivator and supplier of finished pharmaceutical standard medical cannabis products operating from a dedicated 195,506 square meter facility set in the rolling hills of Northern Greece. Hellenic Dynamics is specifically involved in the cultivation, production and export of tetrahydrocannabinol (“THC”) dominant strains of dried medical cannabis flowers and flower extracts to the growing medical cannabis markets across Europe, worth €4.09bn in 2019 and expected to reach €43.3bn by 2027, growing at a CAGR of 29.6% during this period.
Medical cannabis, especially in higher THC doses, has been approved for use in the United Kingdom and Germany plus 24 other European countries for conditions including but not limited to chronic pain, Spinal cord treatment, Anxiety, HIV/AIDS Appitite loss, Multiple Sclerosis, Crohn’s disease, PTSD, Chemotherapy side effects, Glaucoma, Anorexia, Lennox-Gastaut syndrome, Alzheimer’s, Dravet syndrome, Tourette’s syndrome, Intractable spasticity and Cachexia.
Hellenic was awarded its licence from the Greek government in 2019 for a total of 40,000 square meters of active cultivation area within our facility, with no limitations on the THC content of the cultivars grown, the overall volume of production or total export quantities of flowers per annum. This is one of the largest licences of its kind issued in Europe due to the size and scale of the facility and the high regulatory standards under which Hellenic Dynamics operates.
Hellenic Dynamics has an experienced management team with significant medial cannabis cultivation and business development experience. This skillset is underpinned by a number of high profile partnerships and collaboration agreements that cover all aspects of the Company’s marketing, sales, security and existing legislative and legal frameworks both domestically and for target European sales territories.
This is one of the largest licences of its kind issued in Europe due to the size and scale of the facility and the high regulatory standards under which Hellenic Dynamics operates. The licence has no limitations on the THC content of the cultivars grown, the overall volume of production or export quantities of flowers per annum
New Company Presentation and Facility Presentation
[23/11/2023]Mezzanine loan and posting of circular
[26/10/2023]Annual Report for the period ended 31 March 2023
[31/07/2023]Successful Application for EU Grant
[31/07/2023]Repayment of Convertible Loan Note
[06/07/2023]Signing of MoU with Demecan Holding
[13/06/2023]Appointment of Katherine Fleming to Advisory Board
[27/03/2023]Memorandum of Understanding with ELGO-DIMITRA
[22/03/2023]Second Price Monitoring Extension
[14/03/2023]Second Price Monitoring Extension
[16/02/2023]Appointment to Development Team
[26/01/2023]Second Price Monitoring Extension
[05/12/2022][05/12/2022]
Hellenic Dynamics Intention to Float
[28/11/2022]HALF YEAR INTERIM REPORT
28th December 2023
AGREEMENT WITH THE UNIVERSITY OF PATRAS
19th December 2023
NEW COMPANY PRESENTATION
23rd November 2023
FACILITY PRESENTATION
23rd November 2023
RESULTS OF GENERAL MEETING
20th November 2023
ARTICLES OF ASSOCIATION
26th October 2023
RESULT OF AGM
29th September 2023
BUSINESS UPDATE
29th September 2023
NOTICE OF ANNUAL GENERAL MEETING
7th September 2023
ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2023
31st July 2023
A MESSAGE FROM OUR CEO, ON THE EXPANSION OF OUR BUSINESS STRATEGY
8th June 2023
Appointment to Development Team
26 January 2023
Business Update
23 January 2023
Half-year Report
30 December 2022
INVESTOR PRESENTATION
5 December 2022
Hellenic Information Document
5 December 2022
Hellenic Investor Memorandum
5 December 2022
Prospectus
14 November 2022
Hellenic Dynamics PLC Incorporated in England and Wales with registered No. 14025108
The company is subject to the UK City Code on Takeovers and Mergers.
Registered Office Address21 Arlington Street
London
SW1A 1RN
Professional Advisors
[01] Financial Advisor
Cairn Financial
Advisors
3rd Floor, 80
Cheapside
London
EC2V 6EE
[02] Broker
Peterhouse Capital
3rd Floor, 80
Cheapside
London
EC2V 6EE
[03] Reporting
accountants
PKF Littlejohn LLP
15 Westferry Circus
London
E14 4HD
[04] Public & investor
relations
J&H Communications
13 Soho Square
London
W1D 3QF
[05] Registrars
SLC Registrars
42-50 Hersham Road
Walton-On-Thames
Surry
KT12 1RZ
The Directors are committed to maintaining high standards of corporate governance, and propose, so far as is practicable given the Company’s size and nature, to comply with the QCA Code.
The Board has established Board Committees for Audit & Risk, Remuneration, Sales and Nominations and is committed to developing further policies and procedures which reflect the principles of good governance.
The Company has adopted a share dealing code for the Directors and will take steps to ensure compliance by the Directors and any relevant employees with the terms of this code.
The Directors have established financial controls and reporting procedures which are considered appropriate given the size of and structure of the Company. These controls will continue to be reviewed as the Company develops and will be revised accordingly.
The Directors have established financial controls and reporting procedures which are considered appropriate given the size of and structure of the Company. These controls will continue to be reviewed as the Company develops and will be revised accordingly.